Erin M. Lavelle - May 11, 2021 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role
Director
Signature
/s/ Kris McGrew, Attorney-in-Fact for Erin M. Lavelle
Stock symbol
NLTX
Transactions as of
May 11, 2021
Transactions value $
$0
Form type
4
Date filed
5/13/2021, 05:37 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NLTX Stock Option (Right to Buy) Award $0 +25K $0.00 25K May 11, 2021 Common Stock 25K $11.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/12 of the total shares monthly beginning June 11, 2021 until the option is fully vested on May 11, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.